Detail akcie Takeda Pharmactl Depository Receipt online

Business Summary: Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2026, Takeda Pharmaceutical Co Ltd (ADR) revenues decreased 2% to Y4.506T. Net loss applicable to common stockholders totaled Y152.39B vs. income of Y107.93B. Revenues reflect Intellectual Property And Service Revenue segment decrease of 3% to Y82.61B, United States segment decrease of 9% to Y2.165T, Asia segment decrease of 1% to Y98.67B.